Awards to the Institution
| Funding | |||
|---|---|---|---|
| Early Translational II: | John Dimos | New Drug Discovery for SMA using Patient-derived Induced Pluripotent Stem Cells | $5,665,887 |
| Basic Biology II: | John Dimos | Cellular Reprogramming: Dissecting the Molecular Mechanism and Enhancing Efficiency | $1,458,000 |
Total: $7,123,887.00 |
